Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A Argiriadi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Bioorganic & Medicinal Chemistry Letters|September 16, 2015
Structure activity optimization of 6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazines as Jak1 kinase inhibitorsMichael Friedman, Kristine E Frank, Ana Aguirre, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimizationChristopher M Harris, Anna M Ericsson, Maria A Argiriadi, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2019
Inhibition of Interleukin-23-Mediated Inflammation with a Novel Small Molecule Inverse Agonist of ROR<i>γ</i>tStephen B Gauld, Sebastien Jacquet, Donna Gauvin, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2019
Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonistsJérôme Amaudrut, Maria A Argiriadi, Martine Barth, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding modeMaria A Argiriadi, Anna M Ericsson, Christopher M Harris, et al.
Scientific Reports|August 26, 2022
Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal siteEric R Goedken, Maria A Argiriadi, Justin D Dietrich, et al.
Scientific Reports|June 26, 2019
Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque PsoriasisViktor Todorović, Zhi Su, C Brent Putman, et al.
Cell Metabolism|March 2, 2022
Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophagesMarah C Runtsch, Stefano Angiari, Alexander Hooftman, et al.
Journal of Medicinal Chemistry|April 4, 2024
Discovery of Small Molecule Interleukin 17A Inhibitors with Novel Binding Mode and Stoichiometry: Optimization of DNA-Encoded Chemical Library Hits to In Vivo Active CompoundsAshley L Ramos, Eric R Goedken, Kristine E Frank, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Bioorganic & Medicinal Chemistry Letters|September 16, 2015
Structure activity optimization of 6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazines as Jak1 kinase inhibitorsMichael Friedman, Kristine E Frank, Ana Aguirre, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimizationChristopher M Harris, Anna M Ericsson, Maria A Argiriadi, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2019
Inhibition of Interleukin-23-Mediated Inflammation with a Novel Small Molecule Inverse Agonist of ROR<i>γ</i>tStephen B Gauld, Sebastien Jacquet, Donna Gauvin, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2019
Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonistsJérôme Amaudrut, Maria A Argiriadi, Martine Barth, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding modeMaria A Argiriadi, Anna M Ericsson, Christopher M Harris, et al.
Scientific Reports|August 26, 2022
Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal siteEric R Goedken, Maria A Argiriadi, Justin D Dietrich, et al.
Scientific Reports|June 26, 2019
Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque PsoriasisViktor Todorović, Zhi Su, C Brent Putman, et al.
Cell Metabolism|March 2, 2022
Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophagesMarah C Runtsch, Stefano Angiari, Alexander Hooftman, et al.
Journal of Medicinal Chemistry|April 4, 2024
Discovery of Small Molecule Interleukin 17A Inhibitors with Novel Binding Mode and Stoichiometry: Optimization of DNA-Encoded Chemical Library Hits to In Vivo Active CompoundsAshley L Ramos, Eric R Goedken, Kristine E Frank, et al.
Pageof 2